High dose [qnco]
Aspirin [orch, phsu]
Anaemia [dsyn]
Benefit [qnco]
Disease Outcome [fndg]
Kawasaki Disease [dsyn]
Kawasaki Disease [dsyn]
Known [qlco]
Multiple [qnco]
Mucocutaneous Lymph Node Syndrome [dsyn]
Systemic Vasculitis [fndg]
Leading [tmco]
Coronary Lesion [fndg]
Artery [bpoc]
Childhood [tmco]
Intravenous immunoglobulin [aapp, imft, phsu]
Proven [qlco]
Of [spco]
Coronary Lesion [fndg]
Artery [bpoc]
Dose [qnco]
Aspirin [orch, phsu]
Kawasaki Disease [dsyn]
Bleeding [patf]
Anaemia [dsyn]
Aspirin [orch, phsu]
Anaemia [dsyn]
Patients [podg]
Kawasaki Disease [dsyn]
Study [mnob]
Conduct [inbe]
Treatment Efficacy [qlco]
Degree [qlco]
Anaemia [dsyn]
Inflammation [patf]
hepcidin [aapp, horm]
Children [aggp]
Received [qlco]
Combination [qlco]
High dose [qnco]
Aspirin [orch, phsu]
Intravenous immunoglobulin [aapp, imft, phsu]
acute [tmco]
Stage [tmco]
Kawasaki Disease [dsyn]
Received [qlco]
Intravenous immunoglobulin [aapp, imft, phsu]
Alone [qnco]
Materials [sbst]
Methods [inpr]
Kawasaki Disease [dsyn]
Patients [podg]
medical centers [hcro, mnob]
Patients [podg]
Initially [tmco]
treated [topp]
Single [popg]
Dose [qnco]
Intravenous immunoglobulin [aapp, imft, phsu]
g/kg [qnco]
Standard [qlco]
Care [acty]
treatment [ftcn]
Group 1 [inpr]
High dose [qnco]
Aspirin [orch, phsu]
prescribed [hlca]
mg/kg/day [qnco]
Fever [fndg]
Then [tmco]
Low-Dose Aspirin [orch, phsu]
3 5 [qnco]
mg/kg/day [qnco]
prescribed [hlca]
Inflammation [patf]
signs [ftcn]
Resolved [idcn]
Group 2 [inpr]
Low-Dose Aspirin [orch, phsu]
prescribed [hlca]
High dose [qnco]
Aspirin [orch, phsu]
Laboratory Data [idcn]
Collected [idcn]
Group [idcn]
Kawasaki Disease [dsyn]
Patients [podg]
Group 1 [inpr]
N NOS [aapp, imft]
Group 2 [inpr]
N NOS [aapp, imft]
Study [mnob]
Group 1 [inpr]
Group 2 [inpr]
Gender [orga]
P NOS [aapp, imft]
Intravenous immunoglobulin [aapp, imft, phsu]
Resistance [menp]
P NOS [aapp, imft]
Coronary Lesion [fndg]
Artery [bpoc]
formation [biof]
P NOS [aapp, imft]
Duration [tmco]
Hospitalization [hlca]
days [tmco]
P NOS [aapp, imft]
Initially [tmco]
Total white blood cell count [lbpr]
haemoglobin level [lbtr]
Platelet Count [lbpr]
Intravenous immunoglobulin [aapp, imft, phsu]
treatment [ftcn]
Group [idcn]
P NOS [aapp, imft]
Intravenous immunoglobulin [aapp, imft, phsu]
treatment [ftcn]
Group 1 [inpr]
Levels [qlco]
Haemoglobin [aapp, bacs]
P NOS [aapp, imft]
P NOS [aapp, imft]
Smaller [qlco]
Decrease [qlco]
P NOS [aapp, imft]
0.012" [qnco]
hepcidin [aapp, horm]
Delayed [tmco]
Decrease [qlco]
hepcidin [aapp, horm]
Receive [qlco]
Intravenous immunoglobulin [aapp, imft, phsu]
Group 1 [inpr]
P NOS [aapp, imft]
Conclusions [idcn]
High dose [qnco]
Aspirin [orch, phsu]
Acute phase [tmco]
Kawasaki Disease [dsyn]
Benefit [qnco]
Inflammation [patf]
APPEAR [qlco]
Treatment Outcomes [qlco]
High dose [qnco]
Aspirin [orch, phsu]
Acute phase [tmco]
Kawasaki Disease [dsyn]
